Skip to main content

Advertisement

SpringerLink
Log in

Structured diabetes care (Freedom 365*) provides better glycemic control than routine medical care in type 2 diabetes: proof of concept observational study

  • Original Article
  • Published:
International Journal of Diabetes in Developing Countries Aims and scope Submit manuscript

Abstract

Objective

To evaluate the efficacy of a structured diabetes care program (Freedom 365*) as compared to routine medical care (RMC), for management of type 2 diabetes.

Method

A retrospective study of Freedom 365* program versus RMC for diabetes management was carried out. 388 participants (247 men, 141 women; mean age 57 years), who completed 1 year since first contact were analysed. All the participants received a detailed diabetes patient education program, at first contact with the centre and had the choice of opting for either Freedom 365* or RMC.

Results

Out of 388 participants at baseline, 244 (154 men, 90 women) patients opted for Freedom 365* and 144 (93 men, 51 women) opted for RMC. The Freedom 365* group showed 90 % improvement, 2 % had no change and 8 % had deterioration in HbA1c levels. In the RMC group 82 % had improvement, 3 % had no change and 15 % showed deterioration in HbA1c levels. The Freedom 365* group had significantly greater drop in HbA1c [median 1.4 (−2.5, 7.7) vs.0.9 (−2.1, 8.9): p < 0.004], from baseline to follow up. The Freedom group had significantly better compliance in terms of frequency of screening/monitoring per annum for glycemic control [HbA1c –median 3(2, 4) vs. 2(0, 2): p < 0.001], lipid profile (100 vs. 95 %: p < 0.001), microalbuminuria (100 vs. 38 %: p < 0.0001), anaemia screening (100 vs. 29 %: p < 0.0001) and liver function test (100 vs. 29 %: p < 0.0001).

Conclusion

Freedom 365*, a structured diabetes care program of on-going diabetes education, diet and lifestyle correction, biochemical investigations, clinical monitoring and treatment at regular intervals, results in better clinical outcomes and adherence to therapy in management of type 2 diabetes as compared to RMC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Anjana RM, Pradeepa R, Deepa M, Datta M, Sudha V, Unnikrishnan R, et al. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study. Diabetologia. 2011;54:3022–7.

    Article  CAS  PubMed  Google Scholar 

  2. Ramachandran A, Snehalatha C, Ma RCW. Diabetes in South-East Asia: an update for 2013 for the IDF diabetes atlas. Diabetes Res Clin Pract. 2013.

  3. Kumpatla S, Kothandan H, Tharkar S, Viswanathan V. The costs of treating long-term diabetic complications in a developing country: a study from India. J Assoc Physicians India. 2013;61:102–9.

    PubMed  Google Scholar 

  4. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.

    Article  Google Scholar 

  5. (UKPDS) Group: UPDS. Intensive blood-glucose controlwith sulphonylureas or insulin comparedwith conventional treatment andrisk of complications in patients withtype 2 diabetes (UKPDS 33). Lancet. 1998;352:837–52.

    Article  Google Scholar 

  6. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–72.

    Article  CAS  PubMed  Google Scholar 

  7. Gakidou E, Mallinger L, Abbott-Klafter J, Guerrero R, Villalpando S, Ridaura RL, et al. Management of diabetes and associated cardiovascular risk factors in seven countries: a comparison of data from national health examination surveys. Bull World Health Organ. 2011;89:172–83.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Joshi SR, Saboo B, Vadivale M, Dani SI, Mithal A, Kaul U, et al. Prevalence of diagnosed and undiagnosed diabetes and hypertension in India–results from the Screening India’s Twin Epidemic (SITE) study. Diabetes Technol Ther. 2012;14:8–15.

    Article  PubMed  Google Scholar 

  9. Davies MJ, Heller S, Skinner TC, Campbell MJ, Carey ME, Cradock S, et al. Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. BMJ. 2008;336:491–5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Khunti K, Gray LJ, Skinner T, Carey ME, Realf K, Dallosso H, et al. Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: three year follow-up of a cluster randomised controlled trial in primary care. BMJ. 2012;344:e2333.

  11. Olivarius NF, Beck-Nielsen H, Andreasen AH, Hørder M, Pedersen PA. Randomised controlled trial of structured personal care of type 2 diabetes mellitus. BMJ. 2001;323:970–5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Deakin T, McShane CE, Cade JE, Williams RDRR. Group based training for self-management strategies in people with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005:CD003417.

  13. Deakin TA, Cade JE, Williams R, Greenwood DC. Structured patient education: the diabetes X-PERT Programme makes a difference. Diabet Med. 2006;23:944–54.

    Article  CAS  PubMed  Google Scholar 

  14. Yam FK, Adams AG, Divine H, Steinke D, Jones MD. Clinical inertia in type 2 diabetes: a retrospective analysis of pharmacist-managed diabetes care vs. usual medical care. Pharm Pract Granada. 2013;11:203–10.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Standards of medical care in diabetes. Diabetes Care. 2014;37 Suppl 1:S14–80.

    Google Scholar 

Download references

Acknowledgements

The authors acknowledge the contribution of following staff at JUST Diabetes, in providing vital support to carry out the study and collection of data. Doctors (Aditi Laud, Jimit Chowdhary, Nikhil Sardar, Late. Malih Siddiqui, Ragini Maheshwari, Shweta Gupta), diabetes educators (Mr. Sudhakar Singh, Priyanka Dhane, Amreen Shaikh), dieticians (Alpana Cheulkar, Reema Soni, Hetal sharma, Ushma Karia, Mukta Agarwal), physiotherapists (Bhoomi Patel, Deepali Pandey, Vaibhavi Satam) Diabetes foot specialists (Aleyamma James, Steffi Thomas, Madhavi Pathare), Lab technicians (Kishori Bhojwani, Rajgopal Shukla, Kruti Desai, Shweta Juvekar), Optometrist (Vini Satra).

Grant support

This work was funded by the management at JUST Diabetes.

Disclosure

All the listed authors do not have any conflict of interest.

Author information

Authors and Affiliations

  1. JUST Diabetes, 201 Sharyans Audeus, Fun Republic Lane, off- New Link Road, Andheri (W), Mumbai, 400053, India

    Dhruv K. Singh & Vikrant Tari

Authors
  1. Dhruv K. Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vikrant Tari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dhruv K. Singh.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Singh, D.K., Tari, V. Structured diabetes care (Freedom 365*) provides better glycemic control than routine medical care in type 2 diabetes: proof of concept observational study. Int J Diabetes Dev Ctries 35, 289–296 (2015). https://doi.org/10.1007/s13410-014-0267-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13410-014-0267-y

Keywords

Search

Navigation